Bayer HealthCare Pharmaceuticals today launched a new tool using a technology that many people with multiple sclerosis (MS) already have in their pockets or purses – their iPhone.
The new iPhone application, myBETAapp™, provides tools that are customized for Betaseron® (interferon beta-1b) patients, making it the first application developed for use with a specific MS medication....
Read More - http://www.msrc.co.uk/index.cfm/fuseact ... ageid/1902